this post was submitted on 08 Apr 2025
12 points (92.9% liked)

Politics

679 readers
207 users here now

For civil discussion of US politics. Be excellent to each other.

Rule 1: Posts have the following requirements:
▪️ Post articles about the US only

▪️ Title must match the article headline

▪️ Recent (Past 30 Days)

▪️ No Screenshots/links to other social media sites or link shorteners

Rule 2: Do not copy the entire article into your post. One or two small paragraphs are okay.

Rule 3: Articles based on opinion (unless clearly marked and from a serious publication-No Fox News or equal), misinformation or propaganda will be removed.

Rule 4: Keep it civil. It’s OK to say the subject of an article is behaving like a jerk. It’s not acceptable to say another user is a jerk. Cussing is fine.

Rule 5: Be excellent to each other. Posts or comments that are homophobic, transphobic, racist, sexist, ableist, will be removed.

Rule 6: Memes, spam, other low effort posting, reposts, advocating violence, off-topic, trolling, offensive, regarding the moderators or meta in content may be removed at any time.

Rule 7. No conjecture type posts (this could, might, may, etc.). Only factual. If the headline is wrong, clarify within the body. More info

Bookmark Vault of Trump's First Term

USAfacts.org

The Alt-Right Playbook

Media owners, CEOs and/or board members

Video: Macklemore's new song critical of Trump and Musk is facing heavy censorship across major platforms.

founded 2 years ago
MODERATORS
 

The federal agency now headed by former television host Mehmet Oz announced Monday that it is substantially boosting payments to privately run Medicare Advantage plans, a boon for an industry notorious for overcharging taxpayers and denying patients necessary care.

The Centers for Medicare and Medicaid Services (CMS) said it is jacking up payments to Medicare Advantage (MA) plans by more than 5% for 2026—an increase of over $25 billion. That's more than double the increase proposed by the Biden administration.

no comments (yet)
sorted by: hot top controversial new old
there doesn't seem to be anything here